Clinicopathological and prognostic value of transforming acidic coiled-coil-containing protein 3 (TACC3) expression in soft tissue sarcomas

• Published in: PloS one Vol. 12; no. 11; p. e0188096
• Main Authors: Matsuda, Kotaro, Miyoshi, Hiroaki, Hiraoka, Koji, Yokoyama, Shintaro, Haraguchi, Toshiaki, Hashiguchi, Toshihiro, Hamada, Tetsuya, Shiba, Naoto, Ohshima, Koichi
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 14-11-2017; Public Library of Science (PLoS)
• Subjects: Aged; Biology and Life Sciences; Development and progression; Female; Genetic aspects; Humans; Male; Medicine and Health Sciences; Microtubule-Associated Proteins - metabolism; Middle Aged; Physical Sciences; Physiological aspects; Prognosis; Research and Analysis Methods; Sarcoma; Sarcoma - metabolism; Tumor proteins; Japan
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0188096

Transforming acidic coiled-coil-containing protein 3 (TACC3), a microtubule regulator, is associated with various cancers. However, the relationship between TACC3 and soft tissue sarcomas (STS) remains unclear. We investigated the expression of TACC3 in 136 STS patient samples using immunohistochemical (IHC) staining, and the statistical associations between TACC3 expression and clinicopathological characteristics were evaluated. Additionally, the expression levels of the tumor suppressor p53 and of the cell proliferation marker Ki-67 were also assessed by IHC. High TACC3 expression was detected in 94/136 of STS cases (69.1%), and significantly correlated with higher grade according to the French Fédération Nationale des Centres de Lutte Contre le Cancer system (P<0.0001), poorer tumor differentiation (P<0.0001), increased mitotic counts (P<0.0001), advanced stage per American Joint Committee on Cancer guidelines (P<0.0001), higher p53 expression (P = 0.0487), higher Ki-67 expression (P<0.0001), and undergoing postoperative therapy (P = 0.0001). Disease-free survival (DFS) and overall survival (OS) of patients with high TACC3 expression were significantly shorter (P<0.0001 and P<0.0001, respectively). On multivariate analyses, high TACC3 expression was an independent negative prognostic factor for both DFS and OS (hazard ratio [HR]: 3.074; P = 0.0235 and HR: 8.521; P = 0.0415, respectively). Our results suggest that TACC3 is an independent prognostic factor and may be a novel therapeutic target for the treatment of STS.